Pfizer PFE-0.21%decrease; red down pointing triangle said it is voluntarily withdrawing all lots of its sickle-cell drug Oxbryta in all markets where it is approved, two years after acquiring its ...
Andrew Campbell, director of the Children's National Comprehensive Sickle Cell Disease Program in Washington D.C. 'NOT LIKE HOTCAKES' The companies, doctors and analysts say that more than 80% of ...